Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Journal of Neuro-Oncology|January 9, 2009
Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma modelsMarianne Schrader de Oliveira, Giovana Cechim, Elisandra Braganhol, et al.
Oncology|March 15, 2018
Epidermal Growth Factor Receptor Regulation of Ewing Sarcoma Cell FunctionNathália Kersting, Bárbara Kunzler Souza, Igor Araujo Vieira, et al.
Archives of Pathology & Laboratory Medicine|January 1, 2014
Gastrin-releasing peptide receptor expression in lung cancerJane Mattei, Rosane D Achcar, Carlos H Cano, et al.
Human Immunology|February 19, 2017
Reduced frequency of two activating KIR genes in patients with sepsisLuciana M Oliveira, Pamela Portela, Joice Merzoni, et al.
Clinical Biochemistry|March 8, 2018
Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometryNatália B Andriguetti, Roberta Z Hahn, Lilian F Lizot, et al.
Pharmacogenomics|April 21, 2015
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifenMarina Venzon Antunes, Vanessa de Oliveira, Suziane Raymundo, et al.
Scientific Reports|November 20, 2025
The gastrin-releasing peptide receptor as a potential biomarker for squamous cell carcinomaDanielly Brufatto Olguins, Júlia Caroline Marcolin, Mariane da Cunha Jaeger, et al.
Human Immunology|June 29, 2010
Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetesMariana Jobim, Pedro Chagastelles, Patrícia H Salim, et al.
Human Immunology|December 29, 2009
Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitisTimothy J Wilson, Mariana Jobim, Luiz Fernando Jobim, et al.
Therapeutic Drug Monitoring|April 9, 2015
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen BiotransformationMarina V Antunes, Tatiana Aparecida da Fontoura Timm, Vanessa de Oliveira, et al.
Pageof 15